Cargando…
The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder
OBJECTIVE: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Psiquiatria
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111354/ https://www.ncbi.nlm.nih.gov/pubmed/27798711 http://dx.doi.org/10.1590/1516-4446-2015-1721 |
_version_ | 1783513273015992320 |
---|---|
author | Sampaio, Thiago Lima, Cristiane Corregiari, Fabio Bernik, Marcio |
author_facet | Sampaio, Thiago Lima, Cristiane Corregiari, Fabio Bernik, Marcio |
author_sort | Sampaio, Thiago |
collection | PubMed |
description | OBJECTIVE: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in the central nervous system (CNS) which might be explained by suppression of defensive fixed action patterns. Previous studies have proposed that higher baseline 5-HT concentration and slow decrease in concentration during drug treatment of OCD were predictors of good clinical response to 5-HT reuptake inhibitors. The objective of this study was to investigate whether pre-treatment platelet rich plasma (PRP) 5-HT concentration is associated with latency of treatment response and final response to an ERP protocol for obsessive-compulsive disorder (OCD). METHODS: Thirty adult and treatment-free OCD patients were included in an 8-week, 16-session ERP protocol. 5-HT concentration was determined at baseline and after treatment. Patients with a reduction ≥30% on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at the end of ERP were defined as responders. RESULTS: A positive correlation between baseline 5-HT concentration and reduction of symptoms on the Y-BOCS was observed after 4 weeks. Baseline 5-HT concentration was not correlated with clinical response after 8 weeks of ERP, possibly due to the similar though delayed clinical response of patients with lower (compared to those with higher) baseline 5-HT concentration. Patients with higher 5-HT baseline concentration also showed more improvement in depressive symptoms with treatment. CONCLUSION: The present results partially support the hypothesis of a stress endurance effect of 5-HT in OCD patients. According to the literature, fast onset responders possibly have more or larger 5-HT containing neurons, higher endogenous 5-HT synthesis or lower monoamine oxidase activity; all these hypotheses remain to be investigated. |
format | Online Article Text |
id | pubmed-7111354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Associação Brasileira de Psiquiatria |
record_format | MEDLINE/PubMed |
spelling | pubmed-71113542020-04-02 The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder Sampaio, Thiago Lima, Cristiane Corregiari, Fabio Bernik, Marcio Braz J Psychiatry Original Article OBJECTIVE: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in the central nervous system (CNS) which might be explained by suppression of defensive fixed action patterns. Previous studies have proposed that higher baseline 5-HT concentration and slow decrease in concentration during drug treatment of OCD were predictors of good clinical response to 5-HT reuptake inhibitors. The objective of this study was to investigate whether pre-treatment platelet rich plasma (PRP) 5-HT concentration is associated with latency of treatment response and final response to an ERP protocol for obsessive-compulsive disorder (OCD). METHODS: Thirty adult and treatment-free OCD patients were included in an 8-week, 16-session ERP protocol. 5-HT concentration was determined at baseline and after treatment. Patients with a reduction ≥30% on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at the end of ERP were defined as responders. RESULTS: A positive correlation between baseline 5-HT concentration and reduction of symptoms on the Y-BOCS was observed after 4 weeks. Baseline 5-HT concentration was not correlated with clinical response after 8 weeks of ERP, possibly due to the similar though delayed clinical response of patients with lower (compared to those with higher) baseline 5-HT concentration. Patients with higher 5-HT baseline concentration also showed more improvement in depressive symptoms with treatment. CONCLUSION: The present results partially support the hypothesis of a stress endurance effect of 5-HT in OCD patients. According to the literature, fast onset responders possibly have more or larger 5-HT containing neurons, higher endogenous 5-HT synthesis or lower monoamine oxidase activity; all these hypotheses remain to be investigated. Associação Brasileira de Psiquiatria 2016-10-17 /pmc/articles/PMC7111354/ /pubmed/27798711 http://dx.doi.org/10.1590/1516-4446-2015-1721 Text en http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Sampaio, Thiago Lima, Cristiane Corregiari, Fabio Bernik, Marcio The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder |
title | The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder |
title_full | The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder |
title_fullStr | The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder |
title_full_unstemmed | The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder |
title_short | The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder |
title_sort | putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111354/ https://www.ncbi.nlm.nih.gov/pubmed/27798711 http://dx.doi.org/10.1590/1516-4446-2015-1721 |
work_keys_str_mv | AT sampaiothiago theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder AT limacristiane theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder AT corregiarifabio theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder AT bernikmarcio theputativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder AT sampaiothiago putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder AT limacristiane putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder AT corregiarifabio putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder AT bernikmarcio putativecatalyticroleofhigherserotoninbioavailabilityintheclinicalresponsetoexposureandresponsepreventioninobsessivecompulsivedisorder |